Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers

Hereditary Genetics
doi 10.4172/2161-1041.1000104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Aspirin as a Chemoprevention Agent for Colorectal Cancer

Current Drug Metabolism
Clinical BiochemistryPharmacology
2012English

BRCA1 Mutation and Neuronal Migration Defect: Implications for Chemoprevention

Journal of Medical Genetics
Genetics
2005English

Cisplatin in Breast Cancer Treatment in BRCA1 Carriers

Hereditary Cancer in Clinical Practice
OncologyGenetics
2012English

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Propafenone: A Promising New Antiarrhythmic Agent

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1990English

Repurposing Old Drugs to Chemoprevention: The Case of Metformin

Seminars in Oncology
OncologyHematology
2016English

Uterine Cancer in Jewish Israeli BRCA1/BRCA2 Mutation Carriers

Cancer
Cancer ResearchOncology
2018English

Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

Clinical Cancer Research
Cancer ResearchOncology
2004English

Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy